Quick10K

⚲

Endonovo Therapeutics

Filings

10-Q	2020-09-30	Filed 2020-11-19
10-Q	2020-06-30	Filed 2020-08-19
S-1	2020-06-23	Public Filing
10-Q	2020-03-31	Filed 2020-06-12
10-K	2019-12-31	Filed 2020-05-04
10-Q	2019-09-30	Filed 2019-11-19
10-Q	2019-06-30	Filed 2019-08-13
10-Q	2019-03-31	Filed 2019-05-09
S-1	2019-01-07	Public Filing
10-K	2018-12-31	Filed 2019-04-15
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-13
10-Q	2018-03-31	Filed 2018-05-18
10-K	2017-12-31	Filed 2018-04-06
10-Q	2017-09-30	Filed 2017-11-07
10-Q	2017-06-30	Filed 2017-08-10
10-Q	2017-03-31	Filed 2017-05-12
10-K	2016-12-31	Filed 2017-04-17
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-12
10-Q	2016-03-31	Filed 2016-05-20
10-K	2015-12-31	Filed 2016-04-05
10-Q	2015-09-30	Filed 2015-11-23
10-Q	2015-06-30	Filed 2015-08-19
10-Q	2015-03-31	Filed 2015-05-19
10-K	2014-12-31	Filed 2015-04-03
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-19
10-Q	2014-03-31	Filed 2014-05-15
10-K	2013-12-31	Filed 2014-04-15
10-Q	2013-09-30	Filed 2013-12-18
10-Q	2013-06-30	Filed 2013-08-19
10-Q	2013-03-31	Filed 2013-05-20
10-K	2012-12-31	Filed 2013-04-16
10-K	2012-12-31	Filed 2013-04-16
10-Q	2012-09-30	Filed 2012-11-29
10-Q	2012-06-30	Filed 2012-08-20
10-Q	2012-03-31	Filed 2012-05-21
10-K	2011-12-31	Filed 2012-04-13

Reports

8-K	2020-08-06
8-K	2020-05-20
8-K	2020-05-19
8-K	2020-04-10
8-K	2020-03-02
8-K	2020-01-29
8-K	2019-12-11
8-K	2019-06-10
8-K	2019-01-01
8-K	2018-12-06
8-K	2018-09-18
8-K	2018-08-12

Endonovo Therapeutics Financials

ENDV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2015-06-30	2015-09-30	2015-12-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	111	70	52	11	3	1	18	27	41	79	95	56	113	24	64	90	95	68	665	379	58	548	5
Accounts Receivable		1	1	1	2												7	10	3	3	10	8	11
Inventory
PP&E	5	5	2	2	1	51	74	74	78	78	78	78	78	78	78	78	87	87	87	87	87	89	90
Assets	114	73	1,027	988	969	64	54	62	76	102	264	319	358	203	160	4,612	4,471	4,284	4,711	4,242	3,766	4,123	3,414
Accounts Payable	0	1																		157	199	281	346
Long-Term Debt						43	35	32	29	2,285	1,878	3,194	2,800	3,295	3,640	7,356	7,301	7,489	8,413	8,158	7,480	7,520	7,453
Liabilities	0	1	1,746	2,104	2,395	3,527	5,451	5,991	7,665	7,353	8,783	8,881	13,425	9,357	13,344	14,163	13,094	13,400	18,793	15,634	15,391	20,369	19,980
Stockholders' Equity	114	72	-719	-1,116	-1,426	-3,463	-5,398	-5,929	-7,589	-7,250	-8,519	-8,562	-13,066	-9,154	-13,184	-9,550	-8,623	-9,116	-14,082	-11,392	-11,625	-16,247	-16,566


Income Statement ($'000)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2015-06-30	2015-09-30	2015-12-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	9		2	8	7	0	2	-0	0	0	0	0					7	13	21	42	45	63	54
Cost of Revenue							1	0	0	0	0	0						1	4	8	8	30	9
Gross Profit							1	-0	0	0	0	0						12	17	34	37	33	45
R&D																	114	44	5	111	63	48	35
SG&A
Tax	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	21		-431	-431	-393	-452	-558	-1,281	-2,840	-1,454	-2,219	-740	-7,765	1,858	-6,672	1,769	-619	4,802	-5,948	1,382	-2,406	-7,838	-1,406


Cash Flow ($'000)	2011-06-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-09-30	2015-06-30	2015-09-30	2015-12-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			-20	-176	-33			-429	-211		-776	-659	-434	-914	-829	-813	-591	-742	-830	-716	-528	-688	-1,017
Cash Investing			53	0	0						0	0	0	0	0	-3,000	-9	0	0	0	0	-2	-1
Cash Financing			10	135	25			438	229		792	620	492	825	882	3,826	605	714	1,428	430	208	1,179	475